Extracellular DNA in regulation of multiple myeloma
Extracellular DNA in regulation of multiple myeloma
批准号:
9982212
负责人:
Yulia Nefedova
金额:
$42.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2022-07-31
关键词:
AddressBindingBone MarrowBone Marrow CellsCancer ModelCancer PatientCell CommunicationCellsClinicalDNADataDendritic CellsDiseaseDisease ManagementExtracellular StructureGoalsGrowthHematologic NeoplasmsHematopoietic NeoplasmsHumanIn VitroLinkMalignant NeoplasmsMediatingMolecularMultiple MyelomaMyelogenousMyeloid CellsNatureNuclearOutcomePathway interactionsPatientsPlasma CellsPlayPopulationPre-Clinical ModelProteinsPublicationsRegulationResistanceRoleSerumSignal TransductionTestingTherapeuticXBP1 geneantitumor effectbasecancer cellcancer transplantationcell free DNAchemotherapyclinically relevantextracellularimprovedimproved outcomein vivomacrophagemouse modelneoplastic cellneutrophilnovelnovel therapeuticspathogenperipheral bloodpublic health relevancerelease factorresponsesensortherapeutic targettherapy resistanttranscription factortumor growthtumor microenvironmenttumor progressionuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Multiple myeloma (MM) is a devastating bone marrow (BM) cancer that remains uniformly fatal
despite the emergence of novel therapeutics. The tumor microenvironment promotes tumor
growth and resistance to chemotherapy through poorly understood interactions between tumor
cells and the surrounding BM cells. Our preliminary data demonstrates that a population of BM
mature and immature neutrophils is involved in the regulation of MM chemoresistance. In
response to MM-derived soluble factors, neutrophils can release DNA. This extracellular cell-free
DNA induces the chemoresistance of MM cells, possibly through activation of IRE1/XBP1
pathway of the unfolded protein response (UPR). The goal of this proposal is to determine the
molecular mechanism responsible for cell-free DNA mediated chemoresistance in MM cells and to
develop an approach to target it. By targeting of this novel chemoresistance mechanism we hope
to improve chemotherapy responses and thereby improve MM outcomes. The following specific
aims will be addressed:
Specific Aim 1. Identify the mechanisms and clinical relevance of DNA release by neutrophils in
MM.
Specific Aim 2. Determine the mechanisms of cell-free DNA effect on MM cells.
Specific Aim 3. Determine the role of the UPR in cell-free DNA mediated MM chemoresistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of neonatal inflammation by myeloid-derived suppressor cells
-
批准号:9907154
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2020
-
负责人:Yulia Nefedova
-
依托单位:
Regulation of neonatal inflammation by myeloid-derived suppressor cells
-
批准号:10390328
-
项目类别:
-
资助金额:$59.79万
-
财政年份:2020
-
负责人:Yulia Nefedova
-
依托单位:
Regulation of neonatal inflammation by myeloid-derived suppressor cells
-
批准号:10610350
-
项目类别:
-
资助金额:$63.5万
-
财政年份:2020
-
负责人:Yulia Nefedova
-
依托单位:
Regulation of multiple myeloma by S100A9 protein
-
批准号:9247830
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2016
-
负责人:Yulia Nefedova
-
依托单位:
Regulation of multiple myeloma by S100A9 protein
-
批准号:9099354
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2016
-
负责人:Yulia Nefedova
-
依托单位:
Notch as a New Therapeutic Target in Hematological Malignancies
-
批准号:8837134
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2008
-
负责人:Yulia Nefedova
-
依托单位:
Notch as a New Therapeutic Target in Hematological Malignancies
-
批准号:7525055
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2008
-
负责人:Yulia Nefedova
-
依托单位:
Notch as a New Therapeutic Target in Hematological Malignancies
-
批准号:7684263
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2008
-
负责人:Yulia Nefedova
-
依托单位:
Notch as a New Therapeutic Target in Hematological Malignancies
-
批准号:8106366
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2008
-
负责人:Yulia Nefedova
-
依托单位:
Notch as a New Therapeutic Target in Hematological Malignancies
-
批准号:7899985
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2008
-
负责人:Yulia Nefedova
-
依托单位:
Jak/STAT and dendritic cell differentiation in cancer
-
批准号:7061346
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2004
-
负责人:Yulia Nefedova
-
依托单位:
Jak/STAT and dendritic cell differentiation in cancer
-
批准号:6905614
-
项目类别:
-
资助金额:$5.75万
-
财政年份:2004
-
负责人:Yulia Nefedova
-
依托单位:
Jak/STAT and dendritic cell differentiation in cancer
-
批准号:6789788
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2004
-
负责人:Yulia Nefedova
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: